PL370541A1 - Live attenuated strains of prrs virus - Google Patents

Live attenuated strains of prrs virus

Info

Publication number
PL370541A1
PL370541A1 PL02370541A PL37054102A PL370541A1 PL 370541 A1 PL370541 A1 PL 370541A1 PL 02370541 A PL02370541 A PL 02370541A PL 37054102 A PL37054102 A PL 37054102A PL 370541 A1 PL370541 A1 PL 370541A1
Authority
PL
Poland
Prior art keywords
live attenuated
prrs virus
attenuated strains
strains
prrs
Prior art date
Application number
PL02370541A
Other languages
Polish (pl)
Inventor
Knut Elbers
Stefan Pesch
Bettina Schuetz
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of PL370541A1 publication Critical patent/PL370541A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation
    • C12N2770/10062—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PL02370541A 2001-03-09 2002-03-07 Live attenuated strains of prrs virus PL370541A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27460301P 2001-03-09 2001-03-09

Publications (1)

Publication Number Publication Date
PL370541A1 true PL370541A1 (en) 2005-05-30

Family

ID=23048885

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02370541A PL370541A1 (en) 2001-03-09 2002-03-07 Live attenuated strains of prrs virus

Country Status (12)

Country Link
EP (1) EP1421184A2 (en)
JP (1) JP2004534522A (en)
KR (1) KR20030082960A (en)
BR (1) BR0207988A (en)
CA (1) CA2439254A1 (en)
CZ (1) CZ20032743A3 (en)
HU (1) HUP0303431A2 (en)
MX (1) MXPA03007751A (en)
PL (1) PL370541A1 (en)
RU (1) RU2003129068A (en)
SK (1) SK11282003A3 (en)
WO (1) WO2002072802A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1438969A1 (en) * 2003-01-14 2004-07-21 Universiteit Utrecht Arterivirus marker vaccine
KR20050040172A (en) * 2003-10-27 2005-05-03 주식회사 중앙백신연구소 Method of porcine reproductive and respiratory syndrome inactivated oil vaccine
CA2587849A1 (en) * 2004-11-19 2006-05-26 Intervet International B.V. Porcine reproductive and respiratory syndrome virus strains and compositions
AU2006253891B2 (en) * 2005-02-25 2011-12-01 Zoetis P Llc N Protein Mutants of Porcine reproductive and respiratory syndrome virus
US8709730B2 (en) 2007-04-05 2014-04-29 Icahn School Of Medicine At Mount Sinai Methods of preventing and treating viral infections by inhibiting the deISGylation activity of OTU domain-containing viral proteins
CN101454442A (en) * 2007-06-15 2009-06-10 普泰克国际有限公司 Construction of chimera PRRSV, compositions and vaccine preparations
US7666585B2 (en) 2007-06-15 2010-02-23 Protatek International, Inc. Construction of chimera PRRSV, compositions and vaccine preparations
ES2692809T3 (en) * 2011-02-17 2018-12-05 Boehringer Ingelheim Vetmedica Gmbh New strain of the European PRRSV
KR101420850B1 (en) * 2011-05-30 2014-08-13 건국대학교 산학협력단 A novel virus like particle of Porcine reproductive and respiratory syndrome virus and vaccine thereof
KR101281361B1 (en) * 2011-07-18 2013-07-02 서울대학교산학협력단 Vaccine composition for North American Porcine reproductive and respiratory syndrome virus and mixed vaccine comprising thereof
KR101245029B1 (en) * 2012-01-18 2013-03-18 서울대학교산학협력단 Vaccine composition for Korean Porcine reproductive and respiratory syndrome virus
KR102012109B1 (en) * 2012-05-17 2019-08-19 조에티스 엘엘씨 Effective vaccination against porcine reproductive and respiratory syndrome (prrs) virus prior to weaning
CN103290142B (en) * 2013-03-29 2015-03-11 云南农业大学 A fluorescent quantitative RT-PCR method for detection of a porcine reproductive and respiratory syndrome (PRRS) attenuated vaccine virus content
KR101624485B1 (en) 2014-08-13 2016-05-26 전북대학교산학협력단 Porcine reproductive and respiratory syndrome virus mutant strain and vaccine composition for preventing or treating porcine reproductive and respiratory syndrome comprising the same
CN104694561B (en) * 2015-02-10 2018-02-23 中国农业科学院上海兽医研究所 Express construction method and the application of the PRRSV recombinant plasmids of sea pansy or firefly luciferase gene
CN114502240B (en) * 2019-08-29 2025-05-27 礼蓝美国公司 Porcine reproductive and respiratory syndrome vaccine virus
KR102276341B1 (en) * 2020-01-29 2021-07-12 주식회사 바이오포아 Method for producing European porcine reproductive and respiratory syndrome virus and use thereof
WO2021154055A1 (en) * 2020-01-29 2021-08-05 주식회사 바이오포아 Mutant strain of european porcine reproductive and respiratory syndrome virus and vaccine composition comprising same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2290906C (en) * 1991-06-06 2003-04-01 Stichting Centraal Diergeneeskundig Instituut Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
US6592873B1 (en) * 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
ID23399A (en) * 1997-05-06 2000-04-20 Stichting Dienst Landbouwkundi PRRSV ANTIGENIC WEBSITE TO IDENTIFY PEPTID SEQUENCE FROM PRRS VIRUS USED FOR VACCINES OR DIAGNOSTIC TESTING
WO1998055626A2 (en) * 1997-06-05 1998-12-10 Origen, Inc. Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
CA2366072C (en) * 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Prrsv vaccines
CN1406277A (en) * 2000-01-26 2003-03-26 贝林格尔·英格海姆维特梅迪卡有限公司 Recombinant attenuation of PRRSV
EP1156111A1 (en) * 2000-05-19 2001-11-21 Stichting Dienst Landbouwkundig Onderzoek Chimeric arterivirus-like particles
BR0111366A (en) * 2000-05-24 2003-05-20 Merial Sas Recombinant Porcine Respiratory and Respiratory Syndrome Virus (prrsv) Vaccine
EP1397498A1 (en) * 2001-05-21 2004-03-17 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Delections in arterivirus replicons

Also Published As

Publication number Publication date
WO2002072802A3 (en) 2004-03-11
JP2004534522A (en) 2004-11-18
RU2003129068A (en) 2005-04-10
CA2439254A1 (en) 2002-09-19
MXPA03007751A (en) 2004-11-12
SK11282003A3 (en) 2004-02-03
CZ20032743A3 (en) 2004-02-18
EP1421184A2 (en) 2004-05-26
BR0207988A (en) 2004-10-26
KR20030082960A (en) 2003-10-23
HUP0303431A2 (en) 2004-01-28
WO2002072802A2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
AU2002229390A1 (en) Attenuated live vaccine
HUP0301413A3 (en) Vaccine compositions
IL146389A0 (en) Process for the preparation of dronedarone
IL158066A0 (en) Vaccine composition
PL366990A1 (en) Novel vaccine compositon
GB0130215D0 (en) Vaccine
IL155073A0 (en) Split enveloped virus preparation
IL161070A0 (en) Compositions for the treatment of infectious diseases
AU2002341877A1 (en) Lysin-deficient bacteriophages having reduced immunogenicity
AU7087901A (en) Modified virus
IL158428A0 (en) Vaccine composition comprising at least one hiv virus antigen
SI1368456T1 (en) Anti-bacterial vaccine compositions
IL161026A0 (en) Process for the preparation of citalopram
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU147708S (en) Vacuum
GB0227114D0 (en) Preparation of triethyl phostate
ZA200401211B (en) Antigenic compositions
GB0116857D0 (en) Vapor cleaner
GB0001475D0 (en) Virus strains
EP1447083A4 (en) Preventives/remedies for viral infection
HUP0204176A3 (en) Recombinant attenuation of prrsv
AU3487799A (en) Improved live attenuated viruses for use as vectors or vaccines
GB0023445D0 (en) Attenuated virus vaccine
EP1315507A4 (en) Hpv-specific short-mers
GB0113703D0 (en) Attenuated vaccine

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)